John D. Pediani

Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function

James Ellis, John D. Pediani, Meritxell Canals et al. · Journal of Biological Chemistry · 2006 · 220 citations · Full text

Medicine, Neuroscience, Pharmacology +16

The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism

Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie et al. · Molecular Pharmacology · 2013 · 202 citations

Medicine, Biochemistry, Pharmacology +15

The α1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function

Juan F. López‐Giménez, Meritxell Canals, John D. Pediani et al. · Molecular Pharmacology · 2007 · 159 citations

Life Sciences, Biochemistry, Molecular Biology +17

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice

Kay N. Greenshields, Susan K. Halstead, Femke M.P. Zitman et al. · Journal of Clinical Investigation · 2009 · 122 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins

Juan J. Carrillo, John D. Pediani, Graeme Milligan · Journal of Biological Chemistry · 2003 · 112 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17